Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George I Gavriilidis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Studies in Health Technology and Informatics|August 23, 2024
Machine Learning upon RDF Knowledge Graphs for Drug Safety: A Case Study on Reactome DataKalliopi Kastampolidou, George I Gavriilidis, Pantelis Natsiavas
Studies in Health Technology and Informatics|May 27, 2021
Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR DataVlasios K Dimitriadis, George I Gavriilidis, Pantelis Natsiavas
Artificial Intelligence in Medicine|March 3, 2023
Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligenceStella Dimitsaki, George I Gavriilidis, Vlasios K Dimitriadis, et al.
Drug Safety|October 21, 2021
Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design ApproachGeorge I Gavriilidis, Vlasios K Dimitriadis, Marie-Christine Jaulent, et al.
Computational and Structural Biotechnology Journal|May 9, 2024
A mini-review on perturbation modelling across single-cell omic modalitiesGeorge I Gavriilidis, Vasileios Vasileiou, Aspasia Orfanou, et al.
Studies in Health Technology and Informatics|July 2, 2020
Supporting Active Pharmacovigilance via IT Tools in the Clinical Setting and Beyond: Regulatory and Management AspectsPantelis Natsiavas, George I Gavriilidis, Zacharoula Linardaki, et al.
Bioinformatics (Oxford, England)|February 8, 2025
APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19George I Gavriilidis, Vasileios Vasileiou, Stella Dimitsaki, et al.
Studies in Health Technology and Informatics|May 27, 2021
Using Business Process Management Notation to Model Therapeutic Prescription Protocols: The PrescIT ApproachPantelis Natsiavas, Thanos G Stavropoulos, Antonios Pliatsios, et al.
Haematologica|April 28, 2020
Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemiaGeorge I Gavriilidis, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
International Journal of Oncology|March 1, 2024
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cellsMaria G Kakafika, Areti A Lyta, George I Gavriilidis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|August 23, 2024
Machine Learning upon RDF Knowledge Graphs for Drug Safety: A Case Study on Reactome DataKalliopi Kastampolidou, George I Gavriilidis, Pantelis Natsiavas
Studies in Health Technology and Informatics|May 27, 2021
Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR DataVlasios K Dimitriadis, George I Gavriilidis, Pantelis Natsiavas
Artificial Intelligence in Medicine|March 3, 2023
Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligenceStella Dimitsaki, George I Gavriilidis, Vlasios K Dimitriadis, et al.
Drug Safety|October 21, 2021
Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design ApproachGeorge I Gavriilidis, Vlasios K Dimitriadis, Marie-Christine Jaulent, et al.
Computational and Structural Biotechnology Journal|May 9, 2024
A mini-review on perturbation modelling across single-cell omic modalitiesGeorge I Gavriilidis, Vasileios Vasileiou, Aspasia Orfanou, et al.
Studies in Health Technology and Informatics|July 2, 2020
Supporting Active Pharmacovigilance via IT Tools in the Clinical Setting and Beyond: Regulatory and Management AspectsPantelis Natsiavas, George I Gavriilidis, Zacharoula Linardaki, et al.
Bioinformatics (Oxford, England)|February 8, 2025
APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19George I Gavriilidis, Vasileios Vasileiou, Stella Dimitsaki, et al.
Studies in Health Technology and Informatics|May 27, 2021
Using Business Process Management Notation to Model Therapeutic Prescription Protocols: The PrescIT ApproachPantelis Natsiavas, Thanos G Stavropoulos, Antonios Pliatsios, et al.
Haematologica|April 28, 2020
Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemiaGeorge I Gavriilidis, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
International Journal of Oncology|March 1, 2024
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cellsMaria G Kakafika, Areti A Lyta, George I Gavriilidis, et al.
Pageof 2